漢港控股(01663.HK)附屬公司獲發醫療機構執業許可證
格隆匯7月9日丨漢港控股(01663.HK)宣佈,公司間接非全資附屬公司萍鄉港華口腔醫院有限公司("港華口腔")於近日收到中國江西省萍鄉市衞生健康委員會頒發的《醫療機構執業許可證》,發證日期為2021年7月5日,有效期為五年。
港華口腔獲發《醫療機構執業許可證》,標示着集團的牙科業務已具備對外營業的條件。港華口腔將定為二級甲等口腔醫院,並現已配備兒童口腔專業、口腔頜面外科專業、口腔修復專業、口腔種植專業、口腔正畸專業等科室醫療衞生技術人員,相應儀器設備及制定相關管理制度。
集團發展"大健康"的方向清晰,不但發展藥品檢測業務,並開拓中國國內牙科市場,在短時間得到肯定,將對集團未來業務開展產生積極正面影響,繼續擴大業務範圍,有利於集團對"大健康"業務的佈局,更能與集團的地產開發業務產生協同效應。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.